Besremi (ropeginterferon alfa-2b or ropeginterferon alfa-2b-njft) is a newly-approved, injectable medication used to treat a rare type of blood cancer called polycythemia vera (PV). This medication is a recommended option for certain adults with PV, but it also has many potential risks and side effects.
Polycythemia vera in adults
Besremi (ropeginterferon alfa-2b) is a biologic medication. It affects how the cells in your bone marrow work. This is thought to help lower the production of red blood cells.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Works well to correct blood cell counts in people with PV
Injected every 2 to 4 weeks
Available as a prefilled syringe for easier use
Can use long term (clinical studies lasted 7.5 years)
Can use at home, if approved by your provider
Brand name only, which can be expensive
Has a lot of risks and side effects so you have to be carefully monitored during treatment
Might be hard for some people to administer as instructed
Unknown if safe or works well in children under 18 years old
Besremi (ropeginterferon alfa-2b) can cause serious side effects and problems in many of your body's organs. Your provider will monitor your health regularly throughout treatment to help lower your risk for these problems.
Make sure to have good oral hygiene (regularly brushing your teeth and flossing) and receive check-ups from your dentist regularly. Additionally, make sure to see your optometrist for regular eye check-ups as well. This will help monitor and prevent mouth- and eye-related side effects.
Besremi (ropeginterferon alfa-2b) can make you sleepy and dizzy. Make sure to avoid doing anything that requires you to be alert or have full attention, like driving or operating heavy machinery, until you know how this medication affects you.
Tell your provider about all of the medications you're taking or planning to take, especially any opioids, benzodiazepines, or sleep medications. Taking these medications with Besremi (ropeginterferon alfa-2b) can raise your risk for serious brain and mental health side effects, such as sleepiness, dizziness, depression, and suicide. Don't start any new medications without talking to your provider or pharmacist first.
How to use Besremi (ropeginterferon alfa-2b)
Make sure you know how to give yourself Besremi (ropeginterferon alfa-2b) to avoid accidentally hurting yourself or wasting the medication. Carefully read the instructions for use. Contact your provider or pharmacist if you have any questions on how to use this medication.
If you're traveling on an airplane with Besremi (ropeginterferon alfa-2b), it's recommended to fill out a letter of medical necessity for travel and keep it with you.
Store Besremi (ropeginterferon alfa-2b) in the refrigerator (but don't freeze it). Keep the syringes in the original carton away from light.
When it's time for your dose, take a Besremi (ropeginterferon alfa-2b) prefilled syringe out of the refrigerator, and allow it to reach room temperature. This will take about 15 to 30 minutes. Don't try to warm up the medication any other way (e.g., microwave, under hot water) because you might damage it.
Each Besremi (ropeginterferon alfa-2b) syringe provides a single dose of medication. Throw away the syringe after each use, even if there's still some remaining inside. This is because the syringes don't contain any preservatives to keep germs and bacteria out of the medication once you open it.
After giving yourself the medication, throw away the used syringe and needle in a sharps container or something made of heavy-duty plastic (e.g., empty milk carton, laundry detergent bottle). This lowers the risk of needle-stick injuries. Don't throw them away in your trash can. Learn more about how to throw away your sharps on the FDA's website.
Besremi (ropeginterferon alfa-2b) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Besremi (ropeginterferon alfa-2b) has a black box warning for potentially causing serious or life-threatening mental health, hormone, heart, and blood cell problems. Your provider will monitor your symptoms and order certain lab tests regularly throughout treatment. If you have symptoms of these side effects, seek medical help right away or contact your provider so they can manage your treatment. Specific signs and symptoms for each of these problems include the following.
Besremi (ropeginterferon alfa-2b) can cause several side effects in many other parts of your body. Most are rare, but to lower your risk, your provider will check for symptoms and order lab tests regularly throughout treatment. If you're experiencing any severe side effects, contact your provider. Your provider will adjust your dose or stop your Besremi (ropeginterferon alfa-2b) treatment. Some examples of side effects that can happen throughout your body include the following.
Severe allergic reactions to Besremi (ropeginterferon alfa-2b) are possible, including life-threatening reactions like facial swelling, shock, and anaphylaxis (e.g., closing of the throat). If you notice difficulty breathing, a choking sensation, swelling around your eyes, swelling of the lips or tongue, dizziness, or nausea after using Besremi (ropeginterferon alfa-2b), get medical attention right away.
The starting dose depends on whether you've previously taken a different first-choice medication for PV called hydroxyurea (Hydrea).
Haven't taken hydroxyurea (Hydrea) before: The typical starting dose of Besremi (ropeginterferon alfa-2b) is 100 mcg injected under the skin every 2 weeks.
Switching from hydroxyurea (Hydrea) to Besremi (ropeginterferon alfa-2b) treatment: The typical starting dose of Besremi (ropeginterferon alfa-2b) is 50 mcg injected under the skin every 2 weeks while you continue hydroxyurea (Hydrea). Your provider will slowly lower your dose of hydroxyurea (Hydrea) over 3 months. At the same time, your provider will also slowly raise the dose of Besremi (ropeginterferon alfa-2b). This will help transition your treatment from hydroxyurea (Hydrea) to Besremi (ropeginterferon alfa-2b).
Your provider will adjust your dose based on how well Besremi (ropeginterferon alfa-2b) is working for you and if you're having side effects. The maximum single dose is 500 mcg.
Once your blood cell counts become stable after at least 1 year of Besremi (ropeginterferon alfa-2b) treatment, your provider might change how often you receive this medication from every 2 weeks to once every month.
Current or history of severe mental health problems (e.g., severe depression, suicidal thoughts, suicidal attempt)
Severe allergic reaction to interferons
Moderate or severe liver problems
Current or history of serious or untreated autoimmune problems
Have received a transplant and currently taking immunosuppressants
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.